课题基金 / 基金详情

Addressing conflict of interest driving irrational prescribing of antibiotics in pluralistic health systems: an interventional study in Pakistan

Addressing conflict of interest driving irrational prescribing of antibiotics in pluralistic health systems: an interventional study in Pakistan
解决多元卫生系统中导致抗生素不合理处方的利益冲突:巴基斯坦的一项干预性研究
批准号:
MR/T02349X/1
负责人:
Mishal Khan
金额:
$77.87万
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2020
资助国家:
英国
项目状态:
未结题
起止时间:
2020 至 --

项目摘要

项目成果

Mishal Khan的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The study proposed here applies cutting-edge health policy and systems research to address a critical and poorly addressed global health challenge: conflict of interest (COI) hindering improvements in the quality of care delivered by private healthcare providers. We define COI as a situation whereby the impartiality of a healthcare provider's judgment may be influenced by a secondary interest, such as financial gain, leading to a decision that is not in the patient's best interest. There is strong evidence that private doctors seeking to make a profit from patient consultations often experience a COI resulting in prescription of medication or diagnostic tests that are either unnecessary or more costly than available alternatives. We focus on irrational prescribing of antibiotics by private doctors in Pakistan, the sixth most populous country in the world, where more than 80% of people first seek care at private doctors and where antibiotic usage is among the highest in the world. Studies in Pakistan and other low and middle income countries, including our own earlier research, show that private doctors prescribe multiple antibiotics when patients do not need them in order to receive benefits from pharmaceutical companies, or make profits from the medicine sales. Despite the scale and urgency of this issue, which affects millions of people and drives antimicrobial resistance which can spread across the world, there is extremely limited evidence on strategies that are effective in contexts where resources and political support for the enforcement of rules are low. Therefore, training interventions focusing on increasing knowledge and skills to affect voluntary behaviour change in private providers is the most common approach used. However, these interventions have had limited success when irrational prescribing is mainly motivated by profit-generation rather a lack of knowledge; here norms and values associated with professional ethics are critical to address with interventions.Our study has four linked objectives, which together will generate new evidence about the impact of a continuing medical education intervention with specially designed messages to sensitise doctors to professional ethics and COI, as well as critical insights about barriers that need to be overcome in order to facilitate scale-up of this intervention in the local health system. Since influential stakeholders responsible for addressing practices of private doctors may be crossing professional ethics boundaries themselves, often by having multiple income streams without disclosure, our first objective is to understand how COI and professional ethics is conceptualised by influential stakeholders in Pakistan in order to identify potential supporters and opponents of our intervention. We next focus on private doctors, investigating how they decide what is ethically unacceptable and acceptable with respect to getting personal benefits from prescribing antibiotics. Our third objective is to understand how best to present messages that sensitise private doctors to professional ethics and the role of conflict of interest driving irrational prescription of antibiotics in order to design our intervention. Our final objective is to assess the impact of our intervention on the behaviour and attitudes of private doctors with respect to unethical benefits from pharmaceutical companies for prescribing antibiotics.A key strength of the proposed study is that it has been co-designed with Pakistani researchers and policymakers, building on two previous research council funded projects in Pakistan and Cambodia. In addition to producing new evidence to inform ongoing investments in improving quality of care and tackling antimicrobial resistance, our medical education material on COI can be used for research and training in other settings, and the tools developed as part of our innovative health systems research methods will be made available for future studies.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1186/s12960-020-0452-7
发表时间: 2020-02-11
期刊: HUMAN RESOURCES FOR HEALTH
影响因子: 4.5
作者: [Khan, Mishal S., Bory, Sothavireak, Saphonn, Vonthanak]
通讯作者: Saphonn, Vonthanak
DOI: 10.1136/bmjgh-2022-008596
发表时间: 2022-05
期刊: BMJ GLOBAL HEALTH
影响因子: 8.1
作者: [Khan, Mishal, Rahman-Shepherd, Afifah, Bory, Sothavireak, Chhorn, Sophea, Durrance-Bagale, Anna, Hasan, Rumina, Heng, Sotheara, Phou, Socheata, Prien, Chanra, Probandari, Ari, Saphonn, Vonthanak, Suy, Sovanthida, Wiseman, Virginia, Wulandari, Luh Putu Lila, Hanefeld, Johanna]
通讯作者: Hanefeld, Johanna
DOI: 10.1177/13558196241230853
发表时间: 2024-02-01
期刊: JOURNAL OF HEALTH SERVICES RESEARCH & POLICY
影响因子: 2.4
作者: [Noor,Muhammad Naveed, Rahman-Shepherd,Afifah, Khan,Mishal]
通讯作者: Khan,Mishal
DOI: 10.1136/bmjopen-2022-067233
发表时间: 2022-11-04
期刊: BMJ open
影响因子: 2.9
作者: []
通讯作者:
7
    Combating drug resistance through better governance of unregulated antimicrobial sellers in Cambodia: addressing stakeholder connections & perceptions
    国内基金
    海外基金
    果蝇转座元件和piRNA之间的基因组冲突及对杂交不育的影响
    • 批准号:
      91431101
    • 项目类别:
      重大研究计划
    • 资助金额:
      120.0万元
    • 批准年份:
      2014
    • 负责人:
      陆剑
    • 依托单位:
    自然保护区周边人与野生动物冲突的生态学机制和缓解对策
    • 批准号:
      30360023
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      19.0万元
    • 批准年份:
      2003
    • 负责人:
      杨士剑
    • 依托单位: